Videos

Ryan Haumschild, PharmD, MS, MBA, enlightens the panel on the unique roles of pharmacists in treatment management for patients with mantle cell lymphoma.

Cole McCoy, PharmD, considers if maintenance therapy is standard of care and what is involved with appropriate transitions upon discharge.

It's really important that we capitalize on this time and the impact that pharmacists had to make some of this reform permanent.

Cole McCoy, PharmD, details his experiences with oral maintenance therapies, specifically oral azacitidine.

If we are culturally competent, then we know the impacts of social determinants of health can have and how racism and transphobia homophobia can contribute to the social determinants of health.

Ryan Burke, PharmD, director of professional affairs at Pharmacy Technician Certification Board, discusses how the changing role of pharmacy technicians has also helped the role of the pharmacist.

Every pharmacist knows that if they don't have a well-trained technician available, they're not going to be able to do the things that were so amplified during COVID-19.

Even before the pandemic, pharmacists were playing a really important role in public health, being one of the most accessible health care providers.

Pharmacies have a lot of opportunities to think out of the box, to be innovative, and continue to drive that power of community that we're highlighting at the event here.

Debbie Weitzman of Cardinal Health, discussed how independent retail pharmacies quickly adjusted during the pandemic.

Being able to acknowledge those missteps that may have been made that may have prevented you from delivering as culturally competent care, and being able to recalibrate and to take the correction is an important step.

Ryan Burke, PharmD, director of professional affairs at Pharmacy Technician Certification Board, discusses more advanced roles for pharmacy technicians and how they can continue to grow beyond their current roles.

Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how the COVID-19 pandemic has changed the role of pharmacy technicians and what is expected as we move forward.

Utilizing Multidisciplinary and Patient-Centered Care to Manage Drug Toxicity

Susan Faye Dent, MD, FRCPC, FICQS, provides an overview of the BYLieve study and the impact on treatment options in patients with HR+, HER2- breast cancer.

Cultural competence should be thought in terms of being cognizant that there are differences in every single patient.

After noticing that there were few, if any, children’s books on the subject, Katrina Zearley wrote and published I Think When I Am Older I Might Be a Pharmacist!

CS Family Pharmacy has migrated to a combo-type pharmacy, integrating long term care.

Bunch Pharmacy has been in business for 24 years in the rural area of Alabama.

From the first approved CAR T therapy for multiple myeloma, to the recently-approved ciltacabtagene autoleucel, significant steps have been taken.

Vibhuti Arya Amirfar, PharmD, MPH, discusses building individual and systems resilience to dismantle structural racism in the pharmacy field.

Experts discuss tools and trainings that health care institutions have established during the pandemic to support hematology-oncology pharmacists who are struggling with wellness and mental health challenges.

Experts navigate MCL drug interactions, including those between BTK inhibitors with common anticoagulants and antifungals.

An intelligence-based system could help improve the timeliness of referrals to palliative care and hospice services in a community oncology environment.

Drs Jain and Wang discuss concerns regarding mutations in the treatment setting for patients with mantle cell lymphoma.

The American Diabetes Association guidelines have self-care and lifestyle recommendations for patients and health care professionals.

Learning the Pharmacists' Patient Care Process steps and being mindful or internalizing those can help set best practices for pharmacy team members.

James McCloskey, MD, analyzes result data from the QUAZAR AML-001 trial that focused on oral azacitidine.

Cole McCoy, PharmD, and Danielle Marcotulli, APN, RN, MSN, FNP-BC, AOCNP explain the additional agents being studied as maintenance therapy options.

Joe Duarte, co-founder and president of ContinuumMD, discusses a program model that allows pharmacies to provide virtual and in-person primary care options for rural communities with health care access challenges.